Search For "phase iii"
Updated : 1 year, 7 months ago IST
New Delhi [India], December 16 (ANI): With the start of COVID vaccination an immediate future in India, the phase III clinical trial for indigenously-developed Bharat Biotech's vaccine candidate COVAXIN is witnessing a shortage of volunteer participation, with a high refusal rate 70 per c
Updated : 1 year, 8 months ago IST
New Delhi [India], December 5 (ANI): Haryana Home Minister Anil Vij, who received the first dose of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, during its Phase-III trial in the state two weeks ago, on Saturday said that he has tested positive for the virus.
Kolkata (West Bengal) [India], December 2 (ANI): West Bengal Governor Jagdeep Dhankhar inaugurated the phase III regulatory trial of Bharat Biotech's coronavirus vaccine candidate Covaxin in Kolkata on Wednesday.
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
Hyderabad [India], November 17, (ANI): Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.
Updated : 1 year, 9 months ago IST
New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have announced the completion of enrolment of phase 3 clinical trials for COVISHIELD in India.
New Delhi [India], November 11 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi (AIIMS), Delhi on Wednesday said the results of Pfizer's COVID-19 vaccine phase III trials are very encouraging but preserving it at very low temperatures, -70 degree C, will
New Delhi [India], October 29 (ANI): The Cabinet Committee on Economic Affairs (CCEA) on Thursday approved the Dam Rehabilitation and Improvement Project (DRIP) Phase II and Phase III to improve safety and operational performance of selected dams across the country.
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Updated : 1 year, 10 months ago IST
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia